Modulation of Molecular Biomarker Expression in Response to Chemotherapy in Invasive Ductal Carcinoma

Figure 2

Expression of biomarkers analyzed in blood from healthy women and patients with BC in phases I (before treatment) and II (after treatment).   value ≤ 0.05 was considered significant between phase I and healthy women;   value ≤ 0.05 was considered significant between phase I and phase II.